80
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

ESTIMATION OF LIPOPHILICITY AND RETENTION BEHAVIOR OF SOME ALPHA ADRENERGIC AND IMIDAZOLINE RECEPTOR LIGANDS USING RP-TLC

, , &

REFERENCES

  • Bousquet , P. ; Feldman , J. ; Schwartz , J. Central Cardiovascular Effects of Alpha Adrenergic Drugs: Differences Between Catecholamines and Imidazolines . J. Pharmacol. Exp. Ther. 1984 , 230 , 232 – 236 .
  • Ernsberger , P. ; Meeley , M. P. ; Mann , J. J. ; Reis , D. J. Clonidine Binds to Imidazole Binding Sites as Well as α(2)-Adrenoceptors in the Ventrolateral Medulla. Eur. J. Pharmacol. 1987, 134, 1–13.
  • Li , G. ; Regunathan , S.; Barrow C. J.; Eshraghi J.; Cooper R.; Reis D. J. Agmatine: An Endogenous Clonidine Displacing Substance in the Brain . Science 1994 , 263 , 966 – 969 .
  • Robinson , E. S. J. ; Anderson , N. J. ; Crosby , J. ; Nutt , D. J. ; Hudson , A. L. Endogenous β-Carbolines as Clonidine-Displacing Substances . Ann. N. Y. Acad. Sci. 2003 , 1009 , 157 – 166 .
  • Regunathan , S. ; Reis , D. J. Imidazoline Receptors and Their Endogenous Ligands . Annu. Rev. Pharmacol. Toxicol. 1996 , 36 , 511 – 544 .
  • Ernsberger , P. ; Haxhiu , M. A. The I1-Imidazoline-Binding Site is a Functional Receptor Mediating Vasodepression via the Ventral Medulla . Am. J. Physiol. 1997 , 273 , R1572 – R1579 .
  • Chan , S. L. ; Brown , C. A. ; Scarpello , K. E.; Morgan N. G. The Imidazoline Site Involved in Control of Insulin Secretion: Characteristics That Distinguish It from I1-and I2-Sites . Br. J. Pharmacol. 1994 , 112 , 1065 – 1070 .
  • Head , G. A. ; Mayorov , D. N. Imidazoline Receptors, Novel Agents and Therapeutic Potential . Cardiovasc. Hematol. Agents Med. Chem. 2006 , 4 , 17 – 32 .
  • Nikolic , K. ; Agbaba , D. Imidazoline Antihypertensive Drugs: Selective I1- Imidazoline Receptors Activation . Cardiovasc. Ther. 2012 , 30 , 209 – 216 .
  • Kimura , A. ; Tyacke , R. J. ; Robinson , J. J. ; Husbands , S. M. ; Minchin , M. C. W. ; Nutt , D. J. ; Hudson , A. L. Identification of an Imidazoline Binding Protein: Creatine Kinase and an Imidazoline-2 Binding Site . Brain Res. 2009 , 1279 , 21 – 28 .
  • Olmos , G. ; Alemany , R. ; Boronat , M. A. ; Garcia-Sevilla , J. A. Pharmacologic and Molecular Discrimination of I2-Imidazoline Receptor Subtypes . Ann. N. Y. Acad. Sci. 1999 , 881 , 144 – 160 .
  • Morgan , N. G. ; Chan , S. L. Imidazoline Binding Sites in the Endocrine Pancreas: Can They Fulfill Their Potential as Targets for the Development of New Insulin Secretagogues? Curr. Pharm. Des. 2001 , 7 , 1413 – 1431 .
  • Nikolic , K. ; Filipic , S. ; Agbaba , D. QSAR Study of Imidazoline Antihypertensive Drugs . Bioorg. Med. Chem. 2008 , 16 , 7134 – 7140 .
  • Nikolic , K. ; Filipic , S. ; Agbaba , D. QSAR Study of Selective I1-Imidazoline Receptor Ligands . SAR QSAR Environ. Res. 2009 , 20 , 133 – 144 .
  • Nasal , A. ; Siluk , D. ; Kaliszan , R. Chromatographic Retention Parameters in Medicinal Chemistry and Molecular Pharmacology . Curr. Med. Chem. 2003 , 10 , 381 – 426 .
  • Perisic-Janjic , N. ; Kaliszan , R. ; Wiczling , P. ; Milosevic , N. ; Uscumlic , G. ; Banjac , N. Reversed-Phase TLC and HPLC Retention Data in Correlation Studies with In Silico Molecular Descriptors and Drug Likeness Properties of Newly Synthesize Anticonvulsant Succinimide Derivatives . Mol. Pharmaceutics 2011 , 8 , 555 – 563 .
  • Erić , S. ; Pavlović , M. ; Popović , G. ; Agbaba , D. Study of Retention Parameters Obtained in RP-TLC System and Their Application on QSAR/QSPR of Some Alpha Adrenergic and Imidazoline Receptor Ligands . J. Chromatogr. Sci. 2007 , 45 , 140 – 145 .
  • Šegan , S. ; Trifković , J. ; Verbić , T. ; Opsenica , D. ; Zlatović , M. ; Burnett , J. ; Šolaja , B. ; Milojković-Opsenica , D. Correlation Between Structure, Retention, Property, and Activity of Biologically Relevant 1,7-Bis(aminoalkyl)diazachrysene Derivatives . J. Pharm. Biomed. Anal. 2013 , 72 , 231 – 239 .
  • Kaliszan , R. QSRR: Quantitative Structure-(Chromatographic) Retention Relationships . Chem. Rev. 2007 , 107 , 3212 – 3246 .
  • Nasal , A. ; Bucinski , A. ; Bober , L. ; Kaliszan , R. Prediction of Pharmacological Classification by Means of Chromatographic Parameters Processed by Principal Component Analysis . Int. J. Pharm. 1997 , 159 , 43 – 55 .
  • Detroyer , A. ; Schoonjans , V. ; Questier , F. ; Vander Heyden , Y. ; Borosy , A. P. ; Guo , Q. ; Massart , D. L. Exploratory Chemometric Analysis of the Classification of Pharmaceutical Substances Based on Chromatographic Data . J. Chromatogr. A 2000 , 897 , 23 – 36 .
  • Detroyer , A. ; Vander Heyden , Y. ; Cambre , I. ; Massart , D. L. Chemometric Comparison of Recent Chromatographic and Electrophoretic Methods in a Quantitative Structure-Retention and Retention-Activity Relationship Context . J. Chromatogr. A 2003 , 986 , 227 – 238 .
  • Baczek , T. ; Kaliszan , R. Qunatitative Structure/Retention Relationships in Affinity Chromatography . J. Biochem. Biophys. Methods 2001 , 49 , 83 – 98 .
  • Put , R. ; Perrin , C. ; Quester , F. ; Coomans , D. ; Massart , D. L. ; Vander Heyden , Y. Classification and Regression Tree Analysis for Molecular Descriptor Selection and Retention Prediction in Chromatographic Quantitative Structure-Retention Relationship Studies. J. Chromatogr. A 2003, 988, 261–276.
  • Wiczling , P. ; Nasal , A. ; Kubik , L. ; Kaliszan , R. A New pH/Organic Modifier Gradient RP HPLC Method for Convenient Determination of Lipophilicity and Acidity of Drugs as Applied to Established Imidazoline Agents . Eur. J. Pharm. Sci. 2012 , 47 , 1 – 5 .
  • Bate-Smith , E. C. ; Westall , R. G. Chromatographic Behavior and Chemical Structure. Some Naturally Occurring Phenolic Substances . Biochim. Biophys. Acta 1950 , 4 , 427 – 440 .
  • Becke , A. D. Density-Functional Thermochemistry. III. The Role of Exact Exchange . J. Chem. Phys. 1993 , 98 , 5648 – 5652 .
  • Gaussian 98 (Revision A.7), Frisch, M. J. et al., Gaussian, Inc., Pittsburgh PA, 1998.
  • Remko , M. ; Swart , M. ; Bickelhaupt , F. M. Theoretical Study of Structure, pKa, Lipophilicity, Solubility, Absorption, and Polar Surface Area of Some Centrally Acting Antihypertensives . Bioorg. Med. Chem. 2006 , 14 , 1715 – 1728 .
  • ChemAxon Marvin 5.5.1.0 program, Budapest, Hungary, 2011. www.chemaxon.com/products.html.
  • CS Chem3D Ultra 7.0, Cambridge Soft Corporation, (Property Picker ActiveX Control), 100 Cambridge Park Dr. Cambridge, MA 02140–2317 USA, 2001. http://www.cambridgesoft.com/ .
  • Molinspiration software or free molecular property calculation services, www.molinspiration.com
  • Talete srl, DRAGON (Software for Molecular Descriptor Calculation) Version 6.0 - 2010 - http://www.talete.mi.it/
  • Parr , R. G. ; Pearson , R. G. Absolute Hardness: Companion Parameter to Absolute Electronegativity . J. Am. Chem. Soc. 1983 , 105 , 7512 – 7516 .
  • Tetko IV. Virtual Computational Chemistry Laboratory, www.vcclab.org
  • SciFinder Scholar - CAS, log P calculated using Advanced Chemistry Development (ACD/Labs), Software V11.02 (1994–2013 ACD/Labs), https://scifinder.cas.org/
  • CS Chem Office, Version 7.0, Cambridge Soft Corporation, Cambridge, MA, 2001.
  • Umetrics AB, SIMCA P+program, Version 12.0.0.0, Umea, Sweden, May 20. 2008, www.umetrics.com
  • Eriksson , L. ; Johansson , E. ; Kettaneh-Wold , N. ; Trygg , J. ; Wikstrom , C. ; Wold , S. (Eds.) Multi-and Megavariate Data Analysis. Basic Principles and Applications I, 2nd ed., Umetrics Academy, Umeå, Sweden, 2001.
  • Labute , P. A Widely Applicable Set of Descriptors. J. Mol. Graph. Model. 2000 , 18 , 464 – 477 .
  • Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/ljlc.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.